Amgen
AMGN
1,763 hedge funds and large institutions have $99.8B invested in Amgen in 2018 Q2 according to their latest regulatory filings, with 99 funds opening new positions, 691 increasing their positions, 718 reducing their positions, and 69 closing their positions.
43% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 69
19% more funds holding in top 10
Funds holding in top 10: 72 → 86 (+14)
11% more capital invested
Capital invested by funds: $90B → $99.8B (+$9.82B)
8.59% more ownership
Funds ownership: 73.29% → 81.88% (+8.6%)
1% more funds holding
Funds holding: 1,750 → 1,763 (+13)
4% less repeat investments, than reductions
Existing positions increased: 691 | Existing positions reduced: 718
19% less call options, than puts
Call options by funds: $816M | Put options by funds: $1.01B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.92B |
| 2 |
Two Sigma Advisers
New York
|
+$138M |
| 3 |
BGC
Beutel, Goodman & Co
Toronto,
Ontario, Canada
|
+$109M |
| 4 |
N
Natixis
Paris,
France
|
+$90.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$74.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$250M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$210M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$194M |
| 4 |
BlackRock
New York
|
-$190M |
| 5 |
State Street
Boston,
Massachusetts
|
-$179M |
AMGN Hedge Fund Activity: Q2 2018 in Review
1,763 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2018, worth a combined $99.8B — up 11% from $90B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new AMGN positions and 69 closed out — a net gain of 30 holders — while 691 added to existing stakes and 718 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $4.92B. The largest seller was Goldman Sachs, cutting an estimated $250M.
- 1,763 institutional investors held Amgen (AMGN) as of Q2 2018, up from 1,750 in Q1 2018.
- Funds reported $99.8B of Amgen stock for Q2 2018, up 11% quarter-over-quarter.
- 99 funds opened new Amgen positions in Q2 2018 and 69 closed out, a net change of +30 holders.
- The largest Amgen buyer in Q2 2018 was Fidelity Investments, an estimated $4.92B added.
- The largest Amgen seller in Q2 2018 was Goldman Sachs, an estimated $250M sold.
Based on aggregated 13F filings for Q2 2018.